v3.26.1
Condensed Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 791,245 $ 118,758,596 $ (109,164,636) $ 10,385,205
Balance (in Shares) at Dec. 31, 2024 106,953 3,198      
Stock-based compensation expense 817,503 817,503
Issuance of restricted stock 17,522 17,522
Issuance of restricted stock (in Shares) 250      
Sale of common stock, warrants and pre-funded warrants pursuant to a registration statement on Form S-1 14,377,835 14,377,835
Sale of common stock, warrants and pre-funded warrants pursuant to a registration statement on Form S-1 (in Shares) 3,013      
Fees incurred in connection with equity offerings (1,830,459) (1,830,459)
Warrants exercised for common stock $ 3 22,144 22,147
Warrants exercised for common stock (in Shares) 29,529      
Warrants exercised for common stock on a cashless basis $ 74 (74)
Warrants exercised for common stock on a cashless basis (in Shares) 732,202      
Conversion of Series H preferred stock for common stock $ (472,245) 472,245
Conversion of Series H preferred stock for common stock (in Shares) (310) 215      
Redemption of Series I preferred stock
Redemption of Series I preferred stock (in Shares) (310)      
Series C preferred stock dividends (150,000) (150,000)
Net loss (4,243,658) (4,243,658)
Balance at Jun. 30, 2025 $ 319,000 $ 77 132,485,312 (113,408,294) 19,396,095
Balance (in Shares) at Jun. 30, 2025 106,333 768,407      
Balance at Mar. 31, 2025 $ 319,000 $ 22 132,243,438 (111,355,622) 21,206,838
Balance (in Shares) at Mar. 31, 2025 106,333 223,147      
Stock-based compensation expense 380,693 380,693
Fees incurred in connection with equity offerings (63,764) (63,764)
Warrants exercised for common stock on a cashless basis $ 55 (55)
Warrants exercised for common stock on a cashless basis (in Shares) 545,260      
Series C preferred stock dividends (75,000)   (75,000)
Net loss (2,052,672) (2,052,672)
Balance at Jun. 30, 2025 $ 319,000 $ 77 132,485,312 (113,408,294) 19,396,095
Balance (in Shares) at Jun. 30, 2025 106,333 768,407      
Balance at Dec. 31, 2025 $ 319,000 $ 91 132,597,001 (116,632,063) 16,284,029
Balance (in Shares) at Dec. 31, 2025 106,333 906,059      
Stock-based compensation expense 511,440 511,440
Series C preferred stock dividends (150,000) (150,000)
Net loss (3,003,328) (3,003,328)
Cancellation of restricted stock
Cancellation of restricted stock (in Shares) (6,300)      
Repurchase of Series F preferred stock $ (319,000)
Repurchase of Series F preferred stock (in Shares) (106,333)      
Repurchase of warrants (130,000) (130,000)
Balance at Jun. 30, 2026 $ 90 132,828,442 (119,635,391) 13,193,141
Balance (in Shares) at Jun. 30, 2026 899,759      
Balance at Mar. 31, 2026 $ 319,000 $ 91 132,601,746 (118,083,470) 14,837,367
Balance (in Shares) at Mar. 31, 2026 106,333 906,059      
Stock-based compensation expense 431,695 431,695
Series C preferred stock dividends (75,000) (75,000)
Net loss (1,551,921) (1,551,921)
Cancellation of restricted stock
Cancellation of restricted stock (in Shares) (6,300)      
Repurchase of Series F preferred stock $ (319,000)
Repurchase of Series F preferred stock (in Shares) (106,333)      
Repurchase of warrants (130,000) (130,000)
Balance at Jun. 30, 2026 $ 90 $ 132,828,442 $ (119,635,391) $ 13,193,141
Balance (in Shares) at Jun. 30, 2026 899,759